Emerging fluoroquinolone resistance in bacterial keratitis - A 5-year review

被引:317
作者
Goldstein, MH
Kowalski, RP
Gordon, YJ
机构
[1] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA
[2] Univ Pittsburgh, Inst Eye & Ear, Pittsburgh, PA 15213 USA
关键词
D O I
10.1016/S0161-6420(99)00716-2
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To identify resistance patterns to the fluoroquinolones for patients with bacterial keratitis. Design: Retrospective observational case series, Participants: All cases of bacterial keratitis presenting to the Charles T. Campbell Ophthalmic Microbiology Laboratory at the Eye and Ear Institute of Pittsburgh from January 1993 to December 1997 were reviewed, A total of 1053 ocular isolates from 825 cases of bacterial keratitis were identified, Main Outcome Measures: In vitro laboratory susceptibility testing of ocular isolates to ciprofloxacin and ofloxacin was determined by the Kirby-Bauer disk diffusion method and interpreted using the National Committee for Clinical Laboratory Standards serum standards. Results: The number of cases of bacterial keratitis per year decreased from 284 in 1993 to 75 in 1997, The ratio of gram-positive to gram-negative organisms changed from 81.8%:18.2% in 1993 to 51.4%:48.6% in 1997 (chi-square, 66.00; degrees of freedom, 4; P < 0.000001), Resistance of Staphylococcus aureus to ciprofloxacin significantly increased annually from 5.8% in 1993 to 35.0% in 1997 (chi-square, 19.80; degrees of freedom, 4; P < 0.0001) and for ofloxacin from 4.7% to 35.0% over the same period (chi-square, 21.32; degrees of freedom, 4; P < 0.001). Streptococcus species and coagulase-negative Staphylococcus species showed significant resistance to both fluoroquinolones but no change in resistance over the study period, The gram-negative organisms showed good susceptibility to the fluoroquinolones. Conclusions: This in vitro study shows a significant increased resistance of S. aureus to the fluoroquinolones from 1993 to 1997, In addition, gaps in fluoroquinolone coverage for Streptococcus and coagulase-negative Staphylococcus species raise concern for the use of monotherapy in treating bacterial keratitis, Contrary to what might be expected, the distribution of gram-positive to gram-negative organisms has shifted, with a decrease in the number of gram-positive organisms identified, while the number of gram-negative isolates has remained stable.
引用
收藏
页码:1313 / 1318
页数:6
相关论文
共 34 条
[2]  
BAUM J, 1986, T OPHTHAL SOC UK, V105, P69
[3]  
BAUM JL, 1979, SURV OPHTHALMOL, V24, P97, DOI 10.1016/0039-6257(79)90127-9
[4]   Canadian ciprofloxacin susceptibility study: Comparative study from 15 medical centers [J].
Blondeau, JM ;
Yaschuk, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (07) :1729-1732
[5]   Fluoroquinolones in the treatment of bacterial keratitis [J].
Bower, KS ;
Kowalski, RP ;
Gordon, YJ .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1996, 121 (06) :712-715
[6]   INCREASING RESISTANCE OF STAPHYLOCOCCUS-AUREUS TO CIPROFLOXACIN [J].
DAUM, TE ;
SCHABERG, DR ;
TERPENNING, MS ;
SOTTILE, WS ;
KAUFFMAN, CA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (09) :1862-1863
[7]  
DAVIES J, 1979, REV INFECT DIS, V1, P23
[8]   TOPICAL 0-CENTER-DOT 3-PERCENT CIPROFLOXACIN, NORFLOXACIN, AND OFLOXACIN IN TREATMENT OF BACTERIAL KERATITIS - A NEW METHOD FOR COMPARATIVE-EVALUATION OF OCULAR DRUG PENETRATION [J].
DIAMOND, JP ;
WHITE, L ;
LEEMING, JP ;
HOH, HB ;
EASTY, DL .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1995, 79 (06) :606-609
[9]   EMERGENCE OF BACTERIAL-RESISTANCE TO IMIPENEM AND CIPROFLOXACIN IN A UNIVERSITY HOSPITAL [J].
FASS, RJ ;
BARNISHAN, J ;
AYERS, LW .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 36 (02) :343-353
[10]  
FINLAND M, 1979, REV INFECT DIS, V1, P4